<DOC>
	<DOCNO>NCT00403624</DOCNO>
	<brief_summary>Primary objective : - To evaluate rate response neoadjuvant therapy + radiotherapy Secondary objective : - tolerability ( toxicity ) time progression</brief_summary>
	<brief_title>Evaluation Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>The following information clinical trial provide information purpose allow patient physician initial discussion trial . This information intend complete information trial , contain consideration may relevant potential participation trial , replace advice personal physician health professional . Main criterion list hereafter : Patients measurable , histologically proven rectal cancer . No history previous malignancy adequately treat skin / cervical cancer . Adequate haematological , renal liver function . No cardiopulmonary insufficiency coronary disease . No sensory neuropathy prior study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>